P-c Yang

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

Journal: ESMO open

Published: November 15, 2025

Lung cancer research and treatment: global perspectives and strategic calls to action.

Lung cancer research and treatment: global perspectives and strategic calls to action.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 09, 2024

Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.

Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.

Journal: Cell death and differentiation

Published: September 07, 2018

GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.

GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.

Journal: Oncogene

Published: September 05, 2017

HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.

HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.

Journal: Oncogene

Published: July 06, 2015

Slug is temporally regulated by cyclin E in cell cycle and controls genome stability.

Slug is temporally regulated by cyclin E in cell cycle and controls genome stability.

Journal: Oncogene

Published: April 29, 2013

A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

Journal: Oncogene

Published: February 06, 2013

GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.

GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.

Journal: Oncogene

Published: January 11, 2013

CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.

CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.

Journal: Cell death and differentiation

Published: November 24, 2012

Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease.

Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 14, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026